Vanda Pharmaceuticals
VNDA
#7905
Rank
NZ$0.45 B
Marketcap
$7.74
Share price
-2.66%
Change (1 day)
24.96%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2024 (TTM): -NZ$60.68 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.19 Billion. In 2023 the company made an earning of -NZ$24.61 Million a decrease over its 2022 earnings that were of NZ$11.15 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$60.68 Million146.64%
2023 -NZ$24.61 Million-320.45%
2022 NZ$11.15 M-84.99%
2021 NZ$74.34 M54.8%
2020 NZ$48.02 M19.42%
2019 NZ$40.21 M4.93%
2018 NZ$38.32 M-228.6%
2017 -NZ$29.81 Million-8.98%
2016 -NZ$32.75 Million-53.79%
2015 -NZ$70.86 Million-30.18%
2014 -NZ$0.11 Billion173.08%
2013 -NZ$37.17 Million-25.33%
2012 -NZ$49.77 Million163.61%
2011 -NZ$18.88 Million-221.15%
2010 NZ$15.58 M-124.53%
2009 -NZ$63.54 Million-29.44%
2008 -NZ$90.04 Million-36.2%
2007 -NZ$0.15 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$42.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$22.44 B-34,074.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$17.89 B-27,186.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.43 B-49,186.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.14 Billion 18,258.91%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.24 B-18,627.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$10.38 Million-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.40 B-40,054.64%๐Ÿ‡บ๐Ÿ‡ธ USA